Europe Activated Carbon For Pharma & Healthcare Market Size & Outlook
Related Markets
Europe activated carbon for pharma & healthcare market highlights
- The Europe activated carbon for pharma & healthcare market generated a revenue of USD 81.9 million in 2024.
- The market is expected to grow at a CAGR of 6.3% from 2025 to 2030.
- In terms of segment, powdered was the largest revenue generating form in 2024.
- Other Form is the most lucrative form segment registering the fastest growth during the forecast period.
- Country-wise, France is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 81.9 million |
| Market revenue in 2030 | USD 118.4 million |
| Growth rate | 6.3% (CAGR from 2025 to 2030) |
| Largest segment | Powdered |
| Fastest growing segment | Other Form |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Powdered, Granular, Other Form |
Other key industry trends
- In terms of revenue, Europe region accounted for 18.2% of the global activated carbon for pharma & healthcare market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 323.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Activated Carbon for Pharma & Healthcare Market Scope
Activated Carbon for Pharma & Healthcare Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Karbon | View profile | 1-10 | Lille, Nord-Pas-de-Calais, France, Europe | https://www.karbon.earth/ |
| Boyce Activated Carbon | View profile | 11-50 | Coimbatore, Tamil Nadu, India, Asia | https://carbonsuppliers.com |
| Jacobi Group | View profile | 11-50 | Cottonwood, Arizona, United States, North America | https://www.horseinsure.com/ |
| Haycarb | View profile | 1001-5000 | Colombo, Western, Sri Lanka, Asia | http://www.haycarb.com |
| Donau Carbon | View profile | 251-500 | Dunnellon, Florida, United States, North America | https://www.donau-carbon-us.com/ |
| Noritz Corp | View profile | 7174 | 93 Edo-machi, Chuo-ku, Kobe, Japan, 650-0033 | http://www.noritz.co.jp |
| Calgon Carbon | View profile | 1001-5000 | Pittsburgh, Pennsylvania, United States, North America | http://calgoncarbon.com |
Europe activated carbon for pharma & healthcare market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to activated carbon for pharma & healthcare market will help companies and investors design strategic landscapes.
Powdered was the largest segment with a revenue share of 57.88% in 2024. Horizon Databook has segmented the Europe activated carbon for pharma & healthcare market based on powdered, granular, other form covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Europe activated carbon for pharma & healthcare market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe activated carbon for pharma & healthcare market databook
-
Our clientele includes a mix of activated carbon for pharma & healthcare market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe activated carbon for pharma & healthcare market , including forecasts for subscribers. This continent databook contains high-level insights into Europe activated carbon for pharma & healthcare market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe activated carbon for pharma & healthcare market size, by country, 2018-2030 (US$M)
Europe Activated Carbon for Pharma & Healthcare Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
